Publications by authors named "Derek Wallace"

Claim this Profile
C
Correction: Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand.
Jing Shen, Elizaveta Kharitonova, Anna Tytula, Justyna Zawieja, Samuel Aballea, Derek Wallace

PLoS Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand.
Jing Shen, Elizaveta Kharitonova, Anna Tytula, Justyna Zawieja, Samuel Aballea, Derek Wallace

PLoS Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
Chukiat Sirivichayakul, Shibadas Biswal, Xavier Saez-Llorens, Eduardo López-Medina, Charissa Borja-Tabora, Derek Wallace

J Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrfume: A window to the world's olfactory data.
Elizabeth A Hamel, Jason B Castro, Travis J Gould, Robert Pellegrino, Zhiwei Liang, Derek S Wallace

Sci Data· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Editorial "The increasing use of T-cell stimulation for successful dengue vaccination" in eBioMedicine 2024; 102, 105120. DOI: https://doi.org/10.1016/j.ebiom.2024.105120.
Walid Kandeil, Eduardo Nascimento, Vianney Tricou, Mayuri Sharma, Derek Wallace

EBioMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the dengue vaccine TAK-003 in an outbreak response: Modeling the Sri Lanka experience.
LakKumar Fernando, Randee Kastner, Pujitha Wickramasinghe, Asvini D Fernando, Dulanie Gunasekera, Derek Wallace

PLoS Negl Trop Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Vianney Tricou, Delia Yu, Humberto Reynales, Shibadas Biswal, Xavier Saez-Llorens, Derek Wallace

Lancet Glob Health· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults.
Vianney Tricou, Peter J Winkle, Leslie M Tharenos, Martina Rauscher, Ian Escudero, Derek Wallace

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue.
Xavier Sáez-Llorens, Shibadas Biswal, Charissa Borja-Tabora, LakKumar Fernando, Mengya Liu, Derek Wallace

Am J Trop Med Hyg· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
Vianney Tricou, Brandon Essink, John E Ervin, Mark Turner, Ian Escudero, Derek Wallace

PLoS Negl Trop Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vianney Tricou, Susannah Eyre, Mahadev Ramjee, Paul Collini, Zenaida Mojares, Derek Wallace

Vaccine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Luis Rivera, Shibadas Biswal, Xavier Sáez-Llorens, Humberto Reynales, Eduardo López-Medina, Derek Wallace

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study.
Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilín Rivera, Jennifer Kilbury, Marsha Raanan, Derek Wallace

J Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.
Eduardo López-Medina, Shibadas Biswal, Xavier Saez-Llorens, Charissa Borja-Tabora, Lulu Bravo, Derek Wallace

J Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting.
Vianney Tricou, Raphael Gottardo, Michael A Egan, Frédéric Clement, Geert Leroux-Roels, Derek Wallace

Vaccine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simplified and affordable approach to forest monitoring using single terrestrial laser scans and transect sampling.
Scott Pokswinski, Michael R Gallagher, Nicholas S Skowronski, E Louise Loudermilk, Christie Hawley, Derek Wallace, Jon Wallace

MethodsX· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City.
Shibadas Biswal, Jorge Fernando Mendez Galvan, Mercedes Macias Parra, Juan-Francisco Galan-Herrera, Monica Belisa Carrascal Rodriguez, Derek Wallace

Rev Panam Salud Publica· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial.
Mark Turner, Athanasia Papadimitriou, Peter Winkle, Nathan Segall, Michael Levin, Derek Wallace

Hum Vaccin Immunother· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bis-Quinolinium Cyclophane Blockers of SK Potassium Channels Are Antagonists of M3 Muscarinic Acetylcholine Receptors.
Vladislav Bugay, Derek J Wallace, Bin Wang, Irving Salinas, Adriana Paola Chapparo

Front Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Shibadas Biswal, Charissa Borja-Tabora, Luis Martinez Vargas, Hector Velásquez, Maria Theresa Alera, Derek Wallace

Lancet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
Vianney Tricou, Xavier Sáez-Llorens, Delia Yu, Luis Rivera, José Jimeno, Derek Wallace

Lancet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial.
Vianney Tricou, Jenny G Low, Helen M Oh, Yee-Sin Leo, Shirin Kalimuddin, Derek Wallace

Vaccine· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
Shibadas Biswal, Humberto Reynales, Xavier Saez-Llorens, Pio Lopez, Charissa Borja-Tabora, Derek Wallace

N Engl J Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nexrutine preserves muscle mass similar to exercise in prostate cancer mouse model.
Darpan I Patel, Derek Wallace, Kira Abuchowski, Paul Rivas, Amber Gallegos

Physiol Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology.
Thomas Jaenisch, Kim Hendrickx, Martin Erpicum, Liane Agulto, Kay M Tomashek, Derek Wallace

BMC Med Res Methodol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis